The impact of comorbid pathology on antiinfective protection in patients with COVID-19.

Abstract

The development and sustainability of a specific immune response to SARS- CoV-2 in immunocompetent and immunocompromised patients is crucial for long-term protection. Understanding the risk factors for severe COVID-19 is important both in the clinical setting and at the pathogenetic level and is necessary to assess the risk of severe disease in individual patients, which can be the basis for making therapeutic decisions in patient care. The aim of the study. To establish and evaluate the impact of comorbid pathology on the activity of anti-infective protection in patients with COVID-19.